SCHEMBL3824034

SCHEMBL3824034

O=CCc1ccc(-c2ccc(F)cn2)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
GRIA2 P42262 2/20 0.38
P2RX7 Q99572 1/20 0.36
TP53 P04637 1/20 0.35
PKM P14618 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CYP11B1 P15538 2/20 0.35
CYP11B2 P19099 2/20 0.35
KCNH2 Q12809 5/20 0.35
BACE1 P56817 2/20 0.35
HPGDS O60760 1/20 0.34
PTPN1 P18031 1/20 0.34
PTPN6 P29350 1/20 0.34
PTPN11 Q06124 1/20 0.34
GRM5 P41594 1/20 0.33
GRM2 Q14416 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3821881 0.86 GRIA2 (0.39) NPC1RXFP1GRIA2P2RX7TP53
SCHEMBL3822972 0.80 NPC1 (0.46) NPC1RXFP1GRIA2TP53PKM
SCHEMBL3823523 0.77 GRM5 (0.41) NPC1RXFP1GRIA2P2RX7CYP11B1
SCHEMBL30936174 0.76 CYP11B1 (0.49) NPC1RXFP1GRIA2TP53PKM
SCHEMBL3821944 0.75 KIF11 (0.40) NPC1RXFP1GRIA2P2RX7CYP11B1
SCHEMBL7855627 0.75 SCN9A (0.35) KCNH2BACE1
SCHEMBL1122006 0.75 IDO1 (0.48) SMN1; SMN2KCNH2BACE1
SCHEMBL29953348 0.75 IDO1 (0.48) SMN1; SMN2KCNH2BACE1
SCHEMBL6852510 0.74 ADRB2 (0.36)
SCHEMBL20468884 0.73 GRM5 (0.40) NPC1RXFP1GRIA2KCNH2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091937-A2 SUBSTITUTED IMIDAZOLES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS Merck & Co., Inc. (US) 2009-08-26 EP disclosed
WO-2008051406-A2 SUBSTITUTED IMIDAZOLES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS MERCK & CO., INC. (US) 2008-05-02 WO disclosed